Tomiki Sumiyoshi obtained his M.D. degree and his Ph.D. degree from Kanazawa University, Kanazawa, Japan, and is currently a Clinical Professor and Director of translational research at the Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences. He had training at the Department of Psychiatry, Case Western Reserve University, as a Research Associate from 1993 to 1995, served as a Visiting Professor at the Department of Psychiatry, Vanderbilt University, from 2000 to 2002, and was the Founder of the augmentation pharmacotherapy to ameliorate cognitive impairment of schizophrenia. His research fields include cognitive neuroscience and psychopharmacology, as represented by more than 100 peer-reviewed articles and book chapters. Dr. Sumiyoshi is an Editorial Board Member of Activitas Nervosa Superior and a Cochair of Psychoneurobiology Section of the World Psychiatric Association.
Biography Updated on 28 February 2013